A Study of Doripenem in Infants Less Than 12 Weeks of Age
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure drug levels of doripenem in blood samples collected
before and after administration of doripenem to infants less than 12 weeks of age who are
hospitalized and documented, presumed to have, or are at risk for bacterial infection (s) and
are undergoing treatment with intravenous (i.v.) antibiotics. Safety and tolerability will
also be assessed.